For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
Biotech News: The year 2023 has unfolded as a challenging period for the global biotech industry, witnessing an unprecedented surge in bankruptcies among biotech companies. The struggles to secure financing, coupled with the aftermath of the COVID-19 pandemic, economic fluctuations, and rising inflation rates, have created a perfect storm for the biotech sector. This Biotech News report delves int...
Financial News - Federal Reserve Hikes Interests Rates By 0.25 Percent Mar 23, 2023 2 years ago
Financial News: In the last few hours, the U.S. Federal Reserve announced the raising of its key short-term interest rate by a quarter percentage point, pushing ahead with its aggressive campaign to tame inflation despite banking and financial crisis following the Silicon Valley Bank’s collapse.
This article examines the reasons behind the rate increase, the potential impact on the ...
Sourec:Thailand Medical News Oct 08, 2019 5 years ago
The biotech industry, research facilities, major hospitals and also the stock markets in US and Europe were in a state of shock about the news of the German genetic testing company disclosure of a reversal of its genome sequencing strategy and also the resignation of longtime CEO Peer Schatz.
Qiagen's Ex CEO Peer Schatz.
Qiagen the maker of diagnostic kits for cancer and tuberculosis and al...
Source: Thailand Medical News Jul 17, 2019 5 years ago
Pharmaceuticals and Biotechnology are the hottest sectors at the moment and so many companies are involved in cutting edge product developments and extensive clinical trials. More often than not, if a company has an important breakthrough then it’s stock price generally surges. Over the course of 2019, some biotech stocks have made millions following the surge in the move that biotech ...
Source: Thailand Medical News May 19, 2019 6 years ago
Despite the ongoing China and US trade war that has sent many stock markets into a tumble, US Biotech stocks are still looking promising as ever and will most probably be the most resilient stocks in times of uncertainty. As usual, we are still staying away from Thai Stocks due to so much ongoing political uncertainties despite the elections and even with whatever government that comes into ...
Source: Thailand Medical News Apr 19, 2019 6 years ago
As usual, our advice from the team at Thailand Medical News is to focus on the US stock markets rather than the local stocks due to a variety of reasons. The US stock market looks as promising as ever especially when it comes to healthcare and biotech stocks. The U.S. soon will spend nearly 20% of its gross domestic product on health care. This comes as health care costs outpace the rise...
We continue our series of stock recommendations, still focusing on Medical and Biotech stocks in the US, as considering the political uncertainties facing Thailand, its best to stay clear of the Thailand Stock Market for the rest of the year. Medical and Biotechnology stocks are simultaneously one of the most exciting and one of the riskiest corners of the stock market. Biotech co...
Continuing on our advice of the Global Medical ,Healthcare, Biotech and Pharma Stocks, we continue to advise all in executing caution and due diligence in buying Thai Healthcare, Medical, Pharma Stocks due to recent local Government intervention in the private healthcare sector and putting medical services and products under price control restrictions etc, coupled with the unpredictable political ...
Unfortunately, we do not recommend touching any Thai stocks or even Asian stocks at the moment considering the strong volatility plus pessimistic outlook for Thailand and the region. Furthermore, considering many political uncertainities in Thailand, its best to stay clear on investing in the Thailand SET for the time being.. The US however, still possess many lucrative and interesting deals.
&n...
Source: Zacks Equity Research Oct 23, 2018 6 years ago
October traditionally has been a weak month for stocks. However, biotech stocks have shown significant resilience so far this year, with the iShares Nasdaq Biotechnology ETF (IBB) gaining 11.5% year-to-date (YTD). Additionally, the broader Health Care Select Sector SPDR ETF (XLV) has risen 15.1% YTD, better than the S&P 500’s increase of 9% during the same period.
Health problems...